甲状腺结节粗针活检:操作性能、准确性及并发症
该回顾性研究评估了粗针活检(CNB)作为甲状腺结节首选方法的性能,共纳入3768例患者4112个结节的4412次CNB。以手术或随访至少2年为参考标准,将滤泡性病变和恶性视为阳性时敏感度为96%、特异度为93.7%;并发症罕见,轻微并发症发生率2.2%,严重并发症4例(0.09%)。作者认为CNB准确、并发症少,可在FNAC性能不佳时作为替代方法,非诊断性活检后重复活检有用。
要点
- CNB结果中不足诊断占3.4%、良性84%、滤泡性病变6.3%、恶性6.3%。
- 以滤泡性病变和恶性为阳性,敏感度96%(CI 93.2-97.8)、特异度93.7%(CI 92.9-94.5)。
- 恶性诊断的阳性预测值为98.6%,滤泡性病变诊断的阳性预测值仅12.2%。
核心结论
- 甲状腺结节CNB准确、并发症少,非诊断性和不确定诊断率低;当FNAC性能不佳时可作为替代方法;非诊断性活检后重复活检有用。
研究设计与样本
- 回顾性研究,经机构审查委员会批准,回顾本中心11年间所有CNB;共4412次CNB,涉及3768例患者的4112个结节,其中300次为重复活检;采用超声引导下弹簧加载18G活检针;参考标准为手术诊断或未手术患者至少2年随访。
诊断标准与关键数值
- CNB结果分为四类:不足诊断、良性、滤泡性病变(不确定)、恶性;将滤泡性病变和恶性视为阳性时,敏感度96%(CI 93.2-97.8),特异度93.7%(CI 92.9-94.5);滤泡性病变诊断的阳性预测值12.2%,恶性诊断的阳性预测值98.6%;恶性诊断的恶性似然比841.9(CI 315.8-2313.3),恶性/滤泡性病变诊断的似然比23.4(CI 20.1-27.3),良性诊断的似然比0.04(CI 0.02-0.07)。
临床应用与阅片要点
- CNB可作为FNAC性能不佳时的替代方法;非诊断性活检后重复活检有用;本研究中53次不足诊断活检后重复CNB获得50次诊断结果。
局限性
- 原文为回顾性研究。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the performance of core-needle biopsy (CNB) in thyroid using a cohort of patients in which it was used as first choice.
METHODS: Our institutional review board approved this retrospective study. We reviewed all CNB performed in our center over a period of 11 years. Ultrasound-guided CNBs were performed using a spring-loaded 18-gauge biopsy needle. We used a classification with four diagnostic categories for CNB results: insufficient, benign, follicular lesion (indeterminate), and malignant. Final diagnosis was based on surgical diagnosis or follow-up of at least 2 years in non-operated patients.
RESULTS: The study included 4412 CNB in 4112 nodules of 3768 patients, 300 of them repeated biopsies. Results were 148 insufficient (3.4%), 3706 benign (84%), 278 follicular lesions (6.3%), and 280 malignant (6.3%). Considering follicular lesion and malignancy CNB results as positive (both lead to the recommendation of surgery) sensitivity was 96% (CI 93.2-97.8) and specificity 93.7% (CI 92.9-94.5). Predictive positive value for a follicular lesion diagnosis was 12.2% and for a malignancy diagnosis, 98.6%. CNB likelihood ratio for malignancy of a malignant diagnosis was 841.9 (CI 315.8-2313.3), of a malignant/follicular lesion diagnosis was 23.4 (CI 20.1-27.3), and of a benign diagnosis was 0.04 (CI 0.02-0.07). Repeated CNB in 53 insufficient biopsies obtained 50 diagnostic results. Minor complications occurred in 2.2% of CNB, and major in four procedures (0.09%).
CONCLUSIONS: CNB in thyroid nodules is accurate and has few complications and a low rate of non-diagnostic and indeterminate diagnoses. It can be an alternative method when FNAC has poor performance. Repeating biopsy is useful after non-diagnostic biopsies.
KEY POINTS: • Core-needle biopsy of thyroid has a low ratio non-diagnostic and indeterminate results. • Core-needle biopsy results are highly reliable, especially benign results. • Complication rate of core-needle biopsy of thyroid is low.
引用
- Paja M, Del Cura JL, Zabala R, et al. Core-needle biopsy in thyroid nodules: performance, accuracy, and complications. Eur Radiol. 2019. PMID: 30783787. doi:10.1007/s00330-019-06038-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。